M&A Analyst
Location: Miami, FL
Employment Type: Full Time
Level: Mid-Level
Reports to: Senior M&A Analyst / VP, Finance Department: Finance
About eMed
eMed is a pioneering digital health leader built on its Empathetic AI Population Health Platform. Our primary mission is to provide large employers, state/federal governments, unions, and payers with unique healthcare solutions aimed at reducing obesity, improving employee health, and lowering company healthcare costs. Our integrated GLP-1 medication weight management program utilizes state-of-the-art at-home blood collection kits and connected clinical telehealth services to screen, onboard, and manage qualified candidates, ensuring medication adherence and effective management of side effects through continuous telehealth support.
Position Summary
The M&A Analyst will work with eMed's Senior M&A Analyst and VP, Finance on corporate development and M&A transaction processes, including developing valuation models and pro-forma financial statements, conducting market and competitive research, collecting and reviewing due diligence materials, and supporting post-closing variance analysis and benchmarking. From time to time, the M&A Analyst will support FP&A activities, including budgeting, forecasting, and business analysis in support of executive decision-making.
Essential Duties & Responsibilities M&A and Corporate Development
- Develop valuation models, comparable company and precedent transaction analyses, and pro-forma financial statements using internal and third-party financial, operational, and healthcare data.
- Monitor public competitors, including earnings, KPIs, valuation metrics, private transactions and capital raises, and sell-side guidance.
- Develop market and competitive research for domestic and international opportunities.
- Collect, review, and organize diligence documentation, and present diligence findings and process updates internally.
- Support transaction execution, including process management, term sheet and definitive agreement review, and post-closing variance analysis and benchmarking.
- Summarize, format, and present models and analyses to peers, senior management, and third parties, including recurring executive reporting packages, KPI reporting, board presentations, and investor reporting.
- Build trustworthy relationships with key individuals from acquisition targets and within eMed.